Eris Lifesciences Limited has informed the Exchange regarding 'to the notice convening the 19th Annual General Meeting'.
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has updated the notice for its 19th AGM scheduled on July 25, 2025, which will be held via video conferencing. The company has decided to defer Agenda Item No. 7, which pertains to a reappointment approval, because it is considered premature at this time. All other agenda items (1 to 6 and 8) will be transacted as originally planned. The original AGM notice and annual report for FY 2024-25 had already been dispatched to members on July 2, 2025. If approved by the Depositories/RTA, e-voting will be disabled specifically for the deferred item only.
This is a procedural update with no direct impact on financials or operations. Shareholders should note that one resolution (likely a director or auditor reappointment) will not be voted on at the upcoming AGM, but all other business will proceed normally.